Tekturna® (aliskiren) is supplied as a light-pink, biconvex unscored round tablet containing 150 mg of aliskiren, and as a light-red biconvex ovaloid tablet containing 300 mg of aliskiren. Tablets are imprinted with NVR on one side and IL, IU, on the other side of the 150, and 300 mg tablets, respectively.
All strengths are packaged in bottles and unit-dose blister packages (10 strips of 10 tablets) as described below in Table 4.
Table 4: Tekturna Tablets Supply
|Side 1||Side 2||Bottle of 30||Bottle of 90||Blister Packages of 100|
Store at 25ºC (77ºF); excursions permitted to 15-30ºC (59-86ºF) [see USP Controlled Room Temperature].
Protect from moisture.
Dispense in tight container (USP).
REV: DECEMBER 2007
Novartis Pharmaceuticals Corporation
East Hanover, New Jersey 07936